Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.

Furthermore, an increase in the level of YM1 and ARG1, which are markers of alternative activation, showed an increased trend in MW181-treated hTau mice, but did not reach statistical significance (Fig. 3f ).

also in 111,027 other papers